n 0437, (-)-isomer has been researched along with Emesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hindmarsh, J; Hindmarsh, S; Lee, M; Telford, R | 1 |
| Asgharnejad, M; Bauer, L; Chung, SJ; Jeon, B; Ramirez, F | 1 |
1 trial(s) available for n 0437, (-)-isomer and Emesis
| Article | Year |
|---|---|
Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.
Topics: Activities of Daily Living; Aged; Depression; Dopamine Agonists; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Prospective Studies; Psychiatric Status Rating Scales; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome; Vomiting | 2016 |
1 other study(ies) available for n 0437, (-)-isomer and Emesis
| Article | Year |
|---|---|
The combination of levomepromazine (methotrimeprazine) and rotigotine enables the safe and effective management of refractory nausea and vomiting in a patient with idiopathic Parkinson's disease.
Topics: Administration, Cutaneous; Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Agonists; Female; Humans; Methotrimeprazine; Nausea; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch; Treatment Outcome; Vomiting | 2019 |